SUSAN BLANEY to Protein-Tyrosine Kinases
This is a "connection" page, showing publications SUSAN BLANEY has written about Protein-Tyrosine Kinases.
Connection Strength
0.198
-
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study. Cancer Chemother Pharmacol. 2012 Apr; 69(4):1021-7.
Score: 0.090
-
New approaches to drug development in pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):324-30.
Score: 0.057
-
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jan; 53(1):39-42.
Score: 0.051